P3.02c-063 Lactate Dehydrogenase (LDH) as a Surrogate Biomarker to Checkpoint-Inhibitors for Patient with Advanced Non–Small-Cell Lung Cancer (NSCLC): Topic: IT Biomarkers
暂无分享,去创建一个
E. Felip | A. Navarro | S. Martinez | M. Biosca | S. Perez | M. Vilaró | A. Hernando | J. Aguilar-Company | A. Piera | S. Valverde | N. Pardo | C. Ortiz | Eulalia Scheenaard | A. Martínez | A. M. D. Castro | Fabiola Amair | S. Recasens | LLuisa Carbonell | Andrea Retter | L. Velez | Silvia García Matas